157 related articles for article (PubMed ID: 17346689)
1. Biological variation of Cartilage Oligomeric Matrix Protein (COMP): a proposal to interpret laboratory serial testing.
Brescia V; Tampoia M
Clin Chim Acta; 2007 May; 380(1-2):248-9. PubMed ID: 17346689
[No Abstract] [Full Text] [Related]
2. The reference change value: a proposal to interpret laboratory reports in serial testing based on biological variation.
Ricós C; Cava F; García-Lario JV; Hernández A; Iglesias N; Jiménez CV; Minchinela J; Perich C; Simón M; Domenech MV; Alvarez V
Scand J Clin Lab Invest; 2004; 64(3):175-84. PubMed ID: 15222627
[TBL] [Abstract][Full Text] [Related]
3. Cartilage oligomeric matrix protein in systemic sclerosis.
Yamamoto M; Takahashi H; Suzuki C; Naishiro Y; Yamamoto H; Imai K; Shinomura Y
Rheumatology (Oxford); 2007 Dec; 46(12):1858-9. PubMed ID: 17895282
[No Abstract] [Full Text] [Related]
4. High serum cartilage oligomeric matrix protein determines the subset of patients with early-stage rheumatoid arthritis with high serum C-reactive protein, matrix metalloproteinase-3, and MRI-proven bone erosion.
Fujikawa K; Kawakami A; Tamai M; Uetani M; Takao S; Arima K; Iwamoto N; Aramaki T; Kawashiri S; Ichinose K; Kamachi M; Nakamura H; Origuchi T; Ida H; Aoyagi K; Eguchi K
J Rheumatol; 2009 Jun; 36(6):1126-9. PubMed ID: 19447929
[TBL] [Abstract][Full Text] [Related]
5. Serum or plasma cartilage oligomeric matrix protein concentration as a diagnostic marker in pseudoachondroplasia: differential diagnosis of a family.
Tufan AC; Satiroglu-Tufan NL; Jackson GC; Semerci CN; Solak S; Yagci B
Eur J Hum Genet; 2007 Oct; 15(10):1023-8. PubMed ID: 17579668
[TBL] [Abstract][Full Text] [Related]
6. Cartilage oligomeric matrix protein in patients with juvenile idiopathic arthritis: relation to growth and disease activity.
Bjørnhart B; Juul A; Nielsen S; Zak M; Svenningsen P; Müller K
J Rheumatol; 2009 Aug; 36(8):1749-54. PubMed ID: 19605679
[TBL] [Abstract][Full Text] [Related]
7. Update on cartilage oligomeric matrix protein as a marker of osteoarthritis.
Jordan JM
J Rheumatol; 2005 Jun; 32(6):1145-7. PubMed ID: 15977350
[No Abstract] [Full Text] [Related]
8. The combination of the biomarkers urinary C-terminal telopeptide of type II collagen, serum cartilage oligomeric matrix protein, and serum chondroitin sulfate 846 reflects cartilage damage in hemophilic arthropathy.
Jansen NW; Roosendaal G; Lundin B; Heijnen L; Mauser-Bunschoten E; Bijlsma JW; Theobald M; Lafeber FP
Arthritis Rheum; 2009 Jan; 60(1):290-8. PubMed ID: 19116938
[TBL] [Abstract][Full Text] [Related]
9. High specificity but low sensitivity of the cartilage oligomeric matrix protein (COMP) test in rheumatoid arthritis and osteoarthritis.
Bender AL; da Silveira IG; von Mühlen CA; Staub HL
Clin Chem Lab Med; 2010 Apr; 48(4):569-70. PubMed ID: 20148721
[No Abstract] [Full Text] [Related]
10. Change in serum COMP concentration due to ambulatory load is not related to knee OA status.
Mündermann A; King KB; Smith RL; Andriacchi TP
J Orthop Res; 2009 Nov; 27(11):1408-13. PubMed ID: 19422040
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic impact of contemporary biomarker assays for rheumatoid arthritis.
Nikolaisen C; Rekvig OP; Nossent HC
Scand J Rheumatol; 2007; 36(2):97-100. PubMed ID: 17476614
[TBL] [Abstract][Full Text] [Related]
12. Cartilage oligomeric matrix protein induction of chronic arthritis in mice.
Carlsen S; Nandakumar KS; Bäcklund J; Holmberg J; Hultqvist M; Vestberg M; Holmdahl R
Arthritis Rheum; 2008 Jul; 58(7):2000-11. PubMed ID: 18576344
[TBL] [Abstract][Full Text] [Related]
13. [The Nordic countries--an international engine in laboratory medicine again? Unified reference intervals following new and old cooperation].
Theodorsson E
Lakartidningen; 2004 Mar; 101(10):870-1. PubMed ID: 15055048
[No Abstract] [Full Text] [Related]
14. Transgenic mice expressing D469Delta mutated cartilage oligomeric matrix protein (COMP) show growth plate abnormalities and sternal malformations.
Schmitz M; Niehoff A; Miosge N; Smyth N; Paulsson M; Zaucke F
Matrix Biol; 2008 Mar; 27(2):67-85. PubMed ID: 17889519
[TBL] [Abstract][Full Text] [Related]
15. [Basis for development of a reference system for clinical decisions in liver disease].
Simonsson P
Lakartidningen; 2004 Sep; 101(40):3099. PubMed ID: 15506134
[No Abstract] [Full Text] [Related]
16. [New common reference intervals for clinical chemistry in the Nordic countries. A better basis for clinical assessment and cooperation].
Simonsson P; Mårtensson A; Rustad P
Lakartidningen; 2004 Mar; 101(10):901-5. PubMed ID: 15055053
[TBL] [Abstract][Full Text] [Related]
17. Multicentric reference values: shared reference limits.
Ferré-Masferrer M; Fuentes-Arderiu X; Alvarez-Funes V; Güell-Miró R; Castiñeiras-Lacambra MJ
Eur J Clin Chem Clin Biochem; 1997 Sep; 35(9):715-8. PubMed ID: 9352235
[TBL] [Abstract][Full Text] [Related]
18. Persons and institutions involved in the NORIP project.
Scand J Clin Lab Invest; 2004; 64(4):267-70. PubMed ID: 15223693
[No Abstract] [Full Text] [Related]
19. Anti-cyclic citrullinated peptide antibodies and IL-23p19 in psoriatic arthritis.
Shibata S; Tada Y; Komine M; Hattori N; Osame S; Kanda N; Watanabe S; Saeki H; Tamaki K
J Dermatol Sci; 2009 Jan; 53(1):34-9. PubMed ID: 18752933
[TBL] [Abstract][Full Text] [Related]
20. Cartilage oligomeric matrix protein as a marker of osteoarthritis.
Jordan JM
J Rheumatol Suppl; 2004 Apr; 70():45-9. PubMed ID: 15132354
[No Abstract] [Full Text] [Related]
[Next] [New Search]
